Koji Fukumura

Partner
Cooley

Koji focuses on complex commercial litigation, including the defense of securities class actions, derivative suits, M&A-related class actions and government investigations. He also regularly conducts internal investigations for boards as well as their audit or special litigation committees. Chambers USA has noted Koji is “practical, business-savvy and strategic,” “has great advocacy skills” and has a “wonderful leadership presence.” Koji is a former member of the firm’s board of directors and a past chair of Cooley’s securities litigation practice. He is also a past chair of the American Bar Association’s Litigation Section and an immediate-past member of the American Bar Association’s Board of Governors as well as its Finance Committee and the Standing Committee on Audit.

Koji has defended 100+ shareholder representative matters, including securities class actions, derivative suits, M&A class actions and breach of fiduciary duty class actions. His practice includes representing companies such as Qualcomm, GNC Holdings, Allbirds, IonQ, FIGS, CD Projekt RED, THQ, Stratasys, Horizon Therapeutics, Silverback Therapeutics, Ionis Pharmaceuticals, Acadia Pharmaceuticals, Neurocrine Biosciences, Tableau Software, Brocade, and The Honest Company.

Koji regularly conducts internal investigations for boards as well as their audit or special committees. He also counsels public companies, directors, officers, and principal shareholders on a wide range of issues relating to corporate governance, antitrust/unfair competition, the Foreign Corrupt Practices Act, Securities and Exchange Commission and Financial Industry Regulatory Authority enforcement, insider trading, and disclosure obligations under and compliance with federal and state securities laws.